March 16, 2020 / 9:39 PM / 17 days ago

BRIEF-Azurrx Biopharma Says Co Provided Transchem With 60 Days Prior Written Notice Of Intent To Terminate Sublicene Agreement

March 16 (Reuters) - AzurRx BioPharma Inc:

* AZURRX BIOPHARMA - ON MARCH 11, CO PROVIDED TRANSCHEM WITH 60 DAYS PRIOR WRITTEN NOTICE OF INTENT TO TERMINATE SUBLICENE AGREEMENT

* AZURRX BIOPHARMA - FOCUSING RESOURCES ON DEVELOPMENT OF LEAD DRUG PRODUCT CANDIDATE, MS1819 Source text for Eikon: (bit.ly/2QmpR6d) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below